JP2024535110A5 - - Google Patents

Info

Publication number
JP2024535110A5
JP2024535110A5 JP2024519586A JP2024519586A JP2024535110A5 JP 2024535110 A5 JP2024535110 A5 JP 2024535110A5 JP 2024519586 A JP2024519586 A JP 2024519586A JP 2024519586 A JP2024519586 A JP 2024519586A JP 2024535110 A5 JP2024535110 A5 JP 2024535110A5
Authority
JP
Japan
Prior art keywords
seq
complement
guanine
uracil
arhgef12
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024519586A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024535110A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/077176 external-priority patent/WO2023056295A1/en
Publication of JP2024535110A publication Critical patent/JP2024535110A/ja
Publication of JP2024535110A5 publication Critical patent/JP2024535110A5/ja
Pending legal-status Critical Current

Links

JP2024519586A 2021-09-30 2022-09-28 Rhoグアニンヌクレオチド交換因子12(ARHGEF12)阻害剤による緑内障の治療 Pending JP2024535110A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163250492P 2021-09-30 2021-09-30
US63/250,492 2021-09-30
PCT/US2022/077176 WO2023056295A1 (en) 2021-09-30 2022-09-28 Treatment of glaucoma with rho guanine nucleotide exchange factor 12 (arhgef12) inhibitors

Publications (2)

Publication Number Publication Date
JP2024535110A JP2024535110A (ja) 2024-09-26
JP2024535110A5 true JP2024535110A5 (cg-RX-API-DMAC7.html) 2025-09-30

Family

ID=83996920

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024519586A Pending JP2024535110A (ja) 2021-09-30 2022-09-28 Rhoグアニンヌクレオチド交換因子12(ARHGEF12)阻害剤による緑内障の治療

Country Status (9)

Country Link
US (1) US12577562B2 (cg-RX-API-DMAC7.html)
EP (1) EP4408535A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024535110A (cg-RX-API-DMAC7.html)
KR (1) KR20240099232A9 (cg-RX-API-DMAC7.html)
CN (1) CN118891050A (cg-RX-API-DMAC7.html)
AU (1) AU2022357497A1 (cg-RX-API-DMAC7.html)
CA (1) CA3232251A1 (cg-RX-API-DMAC7.html)
IL (1) IL311711A (cg-RX-API-DMAC7.html)
WO (1) WO2023056295A1 (cg-RX-API-DMAC7.html)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004045644A1 (ja) 2002-11-18 2004-06-03 Santen Pharmaceutical Co., Ltd. Rhoキナーゼ阻害剤とβ遮断薬からなる緑内障治療剤
WO2006104751A2 (en) * 2005-03-30 2006-10-05 The Regents Of The University Of Michigan Methods and compositions for modulating rho-mediated gene transcription
AR057252A1 (es) 2005-12-27 2007-11-21 Alcon Mfg Ltd Inhibicion de rho quinasa mediada por arni para el tratamiento de trastornos oculares
GB201107176D0 (en) * 2011-04-28 2011-06-15 Cxr Biosciences Ltd Pyrrolnitrin derivatives
JP2022508715A (ja) 2018-10-15 2022-01-19 オキュフィア・ファーマ・インコーポレイテッド 緑内障および関連状態の処置のための方法および組成物
CA3126476A1 (en) * 2019-01-23 2020-07-30 Regeneron Pharmaceuticals, Inc. Treatment of ophthalmic conditions with angiopoietin-like 7 (angptl7) inhibitors

Similar Documents

Publication Publication Date Title
US8962582B2 (en) PKR activation via hybridization chain reaction
JP2022523301A5 (cg-RX-API-DMAC7.html)
JP2022524212A (ja) 操作されたmRNA配列及びその使用
JP2021522836A (ja) スプライスオパシーの軽減、及びrnaドミナンス障害の治療のための組成物及び方法
KR20200047779A (ko) 항-vegf로 치료된 연령-관련 황반 변성을 앓고 있는 환자에서의 임상 결과와 유전적 변이체를 연관시키는 방법
JP2023531935A5 (cg-RX-API-DMAC7.html)
TW200911290A (en) RNAI-mediated inhibition of HTRA1 for treatment of macular degeneration
JP2009539960A (ja) 加齢黄斑変性に対する保護および処置
JP2023536437A5 (cg-RX-API-DMAC7.html)
CN101124339A (zh) 使用自我保护寡核苷酸调节基因表达的组合物和方法
TW200914052A (en) RNAi-related inhibition of TNFα signaling pathway for treatment of glaucoma
JP2024524332A5 (cg-RX-API-DMAC7.html)
JP2024529939A5 (cg-RX-API-DMAC7.html)
RU2418594C2 (ru) Лечение заболеваний кишечника
US20250066855A1 (en) Detection of genetic variants of the beta-adrenergic receptor pathway for detecting and treating retinopathy of prematurity
JP2023539742A5 (cg-RX-API-DMAC7.html)
JP2022525545A5 (cg-RX-API-DMAC7.html)
CN116889627A (zh) 用固醇调节元件结合转录因子1(srebf1)抑制剂治疗脂质水平升高
JP2024536491A5 (cg-RX-API-DMAC7.html)
JP2024531507A5 (cg-RX-API-DMAC7.html)
JP2022525546A5 (cg-RX-API-DMAC7.html)
JP2024528284A5 (cg-RX-API-DMAC7.html)
Ghazalah et al. Genetic study of I kappa B alpha gene promoter polymorphism associated with hepatitis C virus in Egyptian patients
JP2024545873A5 (cg-RX-API-DMAC7.html)
JP2022515838A5 (cg-RX-API-DMAC7.html)